Clinical distribution and drugresistance of methicillinresistant Staphylococcus aureus
DOI:
Author:
Affiliation:

Clc Number:

R378.1+1

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    ObjectiveTo study the distribution and drugresistance of methicillinresistant Staphylococcus aureus (MRSA), so as to provide reference for rational use of antimicrobial agents in clinic.MethodsData of 756 Staphylococcus isolates from clinical samples in a hospital from May 2008 to May 2010 were analyzed retrospectively.ResultsOf all Staphylococcus, 584 (77.25%) were Staphylococcus aureus, 394 (67.47%) of which were MRSA.MRSA mainly came from respiratory tract (248 isolates, 62.94%) and wound (121 isolates, 30.71%), and were mainly from intensive care unit (ICU) (53.30%) and surgery patients (19.29%). MRSA were all sensitive to vancomycin, teicoplain, and linezolid, but resistant to the other commonly used antimicrobial agents,minimum inhibitory concentration of 5.33% of MRSA to vancomycin was 2 μg /mL.ConclusionMRSA are mainly isolated from respiratory tract and wound of ICU and surgery patients, infection and drug resistance is serious, and has multiple drug resistance ; detection and drug resistant surveillance of MRSA should be strengthened.

    Reference
    Related
Get Citation

徐红云,刘春林,袁文丽,等.耐甲氧西林金黄色葡萄球菌的临床分布及耐药性[J].中国感染控制杂志英文版,2012,11(1):52-54.
XU Hongyun, LIU Chunlin, YUAN Wenli, et al. Clinical distribution and drugresistance of methicillinresistant Staphylococcus aureus[J]. Chin J Infect Control, 2012,11(1):52-54.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 09,2011
  • Revised:September 22,2011
  • Adopted:
  • Online: January 30,2012
  • Published: